Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Benzodiazepines | 41 | 2024 | 1134 | 3.160 |
Why?
|
Anti-Anxiety Agents | 23 | 2021 | 397 | 2.550 |
Why?
|
Psychopharmacology | 15 | 2018 | 145 | 2.500 |
Why?
|
Psychotropic Drugs | 23 | 2018 | 885 | 1.450 |
Why?
|
Psychomotor Agitation | 11 | 2022 | 303 | 1.440 |
Why?
|
Depressive Disorder | 33 | 2007 | 3727 | 1.090 |
Why?
|
Antipsychotic Agents | 28 | 2013 | 3064 | 1.090 |
Why?
|
Antidepressive Agents | 26 | 2015 | 2893 | 1.080 |
Why?
|
Amygdala | 6 | 2024 | 1353 | 0.920 |
Why?
|
Psychiatry | 10 | 2015 | 1699 | 0.800 |
Why?
|
Dementia | 12 | 2022 | 2684 | 0.790 |
Why?
|
Learning | 8 | 2024 | 1737 | 0.740 |
Why?
|
Anxiety Disorders | 11 | 2020 | 2723 | 0.710 |
Why?
|
Clozapine | 8 | 2005 | 504 | 0.630 |
Why?
|
Electroconvulsive Therapy | 11 | 2002 | 498 | 0.570 |
Why?
|
Prefrontal Cortex | 3 | 2020 | 2219 | 0.540 |
Why?
|
Lithium Carbonate | 2 | 2007 | 179 | 0.490 |
Why?
|
Teaching | 5 | 2015 | 1171 | 0.490 |
Why?
|
Alzheimer Disease | 5 | 2021 | 8603 | 0.480 |
Why?
|
Neurons | 10 | 2024 | 9428 | 0.450 |
Why?
|
Mental Disorders | 28 | 2018 | 6823 | 0.450 |
Why?
|
Panic Disorder | 6 | 2019 | 613 | 0.440 |
Why?
|
Homes for the Aged | 4 | 2013 | 273 | 0.430 |
Why?
|
Hospitals, Psychiatric | 5 | 2012 | 318 | 0.420 |
Why?
|
Substance Withdrawal Syndrome | 8 | 2007 | 624 | 0.400 |
Why?
|
Schizophrenia | 14 | 2007 | 6930 | 0.400 |
Why?
|
Hippocampus | 2 | 2024 | 3754 | 0.390 |
Why?
|
Paroxetine | 8 | 2002 | 181 | 0.390 |
Why?
|
Substance-Related Disorders | 16 | 2021 | 4413 | 0.390 |
Why?
|
Haloperidol | 4 | 2005 | 390 | 0.380 |
Why?
|
Psychotic Disorders | 10 | 2013 | 3220 | 0.380 |
Why?
|
Neurosciences | 2 | 2015 | 369 | 0.370 |
Why?
|
Macaca mulatta | 4 | 2020 | 2328 | 0.370 |
Why?
|
Drug Prescriptions | 5 | 2015 | 1668 | 0.360 |
Why?
|
Geriatrics | 4 | 2010 | 387 | 0.350 |
Why?
|
Emotions | 7 | 2010 | 2742 | 0.350 |
Why?
|
Reward | 4 | 2010 | 968 | 0.340 |
Why?
|
Fluoxetine | 6 | 1998 | 728 | 0.330 |
Why?
|
Nursing Homes | 6 | 2013 | 1083 | 0.330 |
Why?
|
Cognition | 8 | 2024 | 6988 | 0.320 |
Why?
|
Mental Health Services | 2 | 2012 | 1716 | 0.320 |
Why?
|
Mental Processes | 1 | 2010 | 244 | 0.310 |
Why?
|
Schizophrenic Psychology | 6 | 2001 | 1645 | 0.310 |
Why?
|
Aggression | 4 | 2008 | 748 | 0.300 |
Why?
|
Avoidance Learning | 1 | 2009 | 247 | 0.290 |
Why?
|
Discrimination Learning | 1 | 2009 | 278 | 0.290 |
Why?
|
Judgment | 1 | 2010 | 272 | 0.290 |
Why?
|
Anticonvulsants | 5 | 2011 | 1910 | 0.280 |
Why?
|
Humans | 177 | 2024 | 761208 | 0.270 |
Why?
|
Dibenzazepines | 3 | 1990 | 26 | 0.270 |
Why?
|
Risperidone | 3 | 2005 | 381 | 0.270 |
Why?
|
Prosencephalon | 1 | 2008 | 305 | 0.270 |
Why?
|
Models, Neurological | 5 | 2024 | 1769 | 0.260 |
Why?
|
Monoamine Oxidase Inhibitors | 7 | 1995 | 153 | 0.260 |
Why?
|
Education, Medical | 2 | 2014 | 1725 | 0.250 |
Why?
|
Lorazepam | 4 | 1991 | 155 | 0.250 |
Why?
|
Antidepressive Agents, Tricyclic | 9 | 2007 | 431 | 0.250 |
Why?
|
Depression | 17 | 2015 | 8132 | 0.240 |
Why?
|
Primates | 1 | 2007 | 521 | 0.240 |
Why?
|
Anxiety | 19 | 2022 | 4569 | 0.230 |
Why?
|
Motivation | 3 | 2010 | 2002 | 0.230 |
Why?
|
Affect | 4 | 2010 | 1486 | 0.220 |
Why?
|
Quinolones | 1 | 2007 | 378 | 0.220 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2008 | 1081 | 0.200 |
Why?
|
Curriculum | 6 | 2014 | 3741 | 0.200 |
Why?
|
Basal Ganglia Diseases | 2 | 2001 | 145 | 0.200 |
Why?
|
Mentally Ill Persons | 2 | 1999 | 125 | 0.190 |
Why?
|
Prescriptions | 1 | 2024 | 386 | 0.190 |
Why?
|
Drug Utilization | 7 | 2013 | 1188 | 0.190 |
Why?
|
Hypnotics and Sedatives | 3 | 2008 | 1178 | 0.180 |
Why?
|
Clinical Trials as Topic | 14 | 2010 | 8003 | 0.180 |
Why?
|
Drug Therapy, Combination | 17 | 2007 | 6304 | 0.180 |
Why?
|
Substance P | 1 | 2001 | 334 | 0.180 |
Why?
|
Alcoholism | 2 | 2007 | 1973 | 0.180 |
Why?
|
Aged | 60 | 2015 | 169288 | 0.170 |
Why?
|
Psychiatric Status Rating Scales | 13 | 2007 | 6011 | 0.170 |
Why?
|
Community Mental Health Centers | 2 | 2011 | 93 | 0.170 |
Why?
|
Borderline Personality Disorder | 3 | 1996 | 766 | 0.170 |
Why?
|
Alprazolam | 1 | 1999 | 103 | 0.160 |
Why?
|
Hostility | 10 | 1977 | 183 | 0.160 |
Why?
|
S-Adenosylmethionine | 1 | 2000 | 218 | 0.160 |
Why?
|
Agoraphobia | 2 | 2003 | 177 | 0.160 |
Why?
|
Human Experimentation | 1 | 1999 | 123 | 0.160 |
Why?
|
Tranylcypromine | 1 | 1998 | 30 | 0.150 |
Why?
|
Consensus | 1 | 2008 | 3134 | 0.150 |
Why?
|
Behavior, Animal | 2 | 2020 | 1873 | 0.150 |
Why?
|
Lithium | 5 | 1995 | 596 | 0.150 |
Why?
|
Attention | 1 | 2008 | 2394 | 0.150 |
Why?
|
Photic Stimulation | 3 | 2009 | 1984 | 0.140 |
Why?
|
Object Attachment | 1 | 2020 | 326 | 0.140 |
Why?
|
Task Performance and Analysis | 2 | 2020 | 763 | 0.140 |
Why?
|
Haplorhini | 2 | 2009 | 523 | 0.140 |
Why?
|
Bipolar Disorder | 5 | 2011 | 5092 | 0.140 |
Why?
|
1-Naphthylamine | 2 | 1996 | 48 | 0.140 |
Why?
|
Long-Term Care | 2 | 1999 | 630 | 0.140 |
Why?
|
Practice Guidelines as Topic | 4 | 2013 | 7400 | 0.140 |
Why?
|
Piperazines | 1 | 2007 | 2522 | 0.140 |
Why?
|
Mother-Child Relations | 1 | 2020 | 495 | 0.130 |
Why?
|
Brain | 8 | 2010 | 27092 | 0.130 |
Why?
|
Receptors, Neurotransmitter | 2 | 1993 | 174 | 0.130 |
Why?
|
Phytotherapy | 1 | 1998 | 296 | 0.130 |
Why?
|
Patient Compliance | 5 | 1995 | 2688 | 0.130 |
Why?
|
Health Policy | 1 | 2008 | 2679 | 0.130 |
Why?
|
Mianserin | 2 | 2007 | 51 | 0.130 |
Why?
|
Depression, Postpartum | 1 | 2020 | 349 | 0.130 |
Why?
|
Psychotherapy | 5 | 2006 | 1646 | 0.130 |
Why?
|
Homovanillic Acid | 2 | 1993 | 75 | 0.120 |
Why?
|
Drug Interactions | 9 | 2008 | 1417 | 0.120 |
Why?
|
Plant Extracts | 1 | 1998 | 496 | 0.120 |
Why?
|
Cognition Disorders | 3 | 2008 | 3976 | 0.120 |
Why?
|
Child Abuse, Sexual | 2 | 1996 | 403 | 0.110 |
Why?
|
Parasympatholytics | 2 | 1991 | 88 | 0.110 |
Why?
|
Advisory Committees | 1 | 2018 | 788 | 0.110 |
Why?
|
Agranulocytosis | 2 | 1990 | 97 | 0.110 |
Why?
|
Anger | 3 | 1995 | 405 | 0.110 |
Why?
|
Oxazepam | 5 | 1983 | 6 | 0.110 |
Why?
|
Age Factors | 17 | 2010 | 18384 | 0.110 |
Why?
|
Drug Therapy | 3 | 1995 | 503 | 0.110 |
Why?
|
Consensus Development Conferences as Topic | 2 | 2010 | 168 | 0.100 |
Why?
|
Legislation, Drug | 2 | 2006 | 214 | 0.100 |
Why?
|
Internationality | 1 | 2018 | 999 | 0.100 |
Why?
|
Isoxazoles | 1 | 1994 | 233 | 0.100 |
Why?
|
Valproic Acid | 1 | 1995 | 443 | 0.100 |
Why?
|
Pancreas | 1 | 1999 | 1684 | 0.100 |
Why?
|
Hyperparathyroidism | 1 | 1993 | 337 | 0.100 |
Why?
|
Fluvoxamine | 2 | 2001 | 78 | 0.090 |
Why?
|
Education, Medical, Continuing | 2 | 2014 | 825 | 0.090 |
Why?
|
Comorbidity | 8 | 2008 | 10516 | 0.090 |
Why?
|
Action Potentials | 2 | 2009 | 1830 | 0.090 |
Why?
|
Animals | 12 | 2020 | 168079 | 0.090 |
Why?
|
Off-Label Use | 1 | 2013 | 185 | 0.090 |
Why?
|
Medicaid | 5 | 2011 | 2813 | 0.090 |
Why?
|
Hypercalcemia | 1 | 1993 | 423 | 0.090 |
Why?
|
ROC Curve | 2 | 2009 | 3584 | 0.090 |
Why?
|
Diazepam | 3 | 1983 | 215 | 0.090 |
Why?
|
Disulfiram | 1 | 1990 | 63 | 0.080 |
Why?
|
Appetitive Behavior | 1 | 2009 | 39 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.080 |
Why?
|
Reinforcement Schedule | 1 | 2009 | 123 | 0.080 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2007 | 4575 | 0.080 |
Why?
|
Suicide | 3 | 2010 | 1602 | 0.080 |
Why?
|
Memory | 4 | 1988 | 2190 | 0.080 |
Why?
|
Chlordiazepoxide | 6 | 1977 | 42 | 0.080 |
Why?
|
Drug Administration Schedule | 8 | 2003 | 4851 | 0.080 |
Why?
|
Blinking | 1 | 2009 | 133 | 0.080 |
Why?
|
Bupropion | 3 | 1999 | 304 | 0.080 |
Why?
|
Group Processes | 5 | 1977 | 228 | 0.080 |
Why?
|
Mental Recall | 2 | 2001 | 1221 | 0.080 |
Why?
|
Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
Akathisia, Drug-Induced | 2 | 1986 | 67 | 0.080 |
Why?
|
Drug Labeling | 1 | 2010 | 248 | 0.070 |
Why?
|
Combined Modality Therapy | 4 | 2008 | 8519 | 0.070 |
Why?
|
Conditioning, Operant | 1 | 2009 | 309 | 0.070 |
Why?
|
Physical Stimulation | 1 | 2009 | 517 | 0.070 |
Why?
|
United States Food and Drug Administration | 3 | 2010 | 1662 | 0.070 |
Why?
|
GABA-A Receptor Agonists | 1 | 2008 | 86 | 0.070 |
Why?
|
Interinstitutional Relations | 1 | 1989 | 236 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2024 | 3805 | 0.070 |
Why?
|
Hospitalization | 4 | 2020 | 10707 | 0.070 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2005 | 1990 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2001 | 489 | 0.070 |
Why?
|
Internship and Residency | 6 | 2015 | 5885 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6224 | 0.070 |
Why?
|
Depressive Disorder, Major | 3 | 2010 | 4767 | 0.070 |
Why?
|
Evidence-Based Practice | 2 | 2023 | 493 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2000 | 10756 | 0.070 |
Why?
|
Female | 46 | 2024 | 392544 | 0.070 |
Why?
|
Conditioning, Classical | 1 | 2009 | 367 | 0.070 |
Why?
|
Male | 47 | 2024 | 360693 | 0.070 |
Why?
|
Public Health Administration | 1 | 1989 | 242 | 0.070 |
Why?
|
Phobic Disorders | 3 | 2001 | 439 | 0.070 |
Why?
|
Attitude of Health Personnel | 4 | 2003 | 3885 | 0.070 |
Why?
|
Arousal | 2 | 2007 | 1171 | 0.070 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2007 | 369 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 1990 | 454 | 0.060 |
Why?
|
Guideline Adherence | 3 | 2013 | 2220 | 0.060 |
Why?
|
Dangerous Behavior | 1 | 1986 | 65 | 0.060 |
Why?
|
Drug Discovery | 2 | 2010 | 1050 | 0.060 |
Why?
|
Piperidines | 1 | 1994 | 1656 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1567 | 0.060 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1072 | 0.060 |
Why?
|
Cannabis | 5 | 1977 | 441 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6635 | 0.060 |
Why?
|
Double-Blind Method | 7 | 2002 | 12341 | 0.060 |
Why?
|
Middle Aged | 30 | 2024 | 220853 | 0.060 |
Why?
|
Massachusetts | 4 | 2012 | 8837 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10218 | 0.060 |
Why?
|
Adult | 37 | 2024 | 221119 | 0.060 |
Why?
|
Tranquilizing Agents | 2 | 1978 | 58 | 0.060 |
Why?
|
Time Factors | 5 | 2020 | 39957 | 0.060 |
Why?
|
Mesencephalon | 1 | 2005 | 332 | 0.060 |
Why?
|
History, 20th Century | 1 | 2011 | 2765 | 0.050 |
Why?
|
Models, Animal | 1 | 2010 | 2115 | 0.050 |
Why?
|
Private Practice | 2 | 1982 | 152 | 0.050 |
Why?
|
Sertraline | 2 | 1996 | 209 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2009 | 6223 | 0.050 |
Why?
|
Injections, Intramuscular | 3 | 1991 | 555 | 0.050 |
Why?
|
Ambulatory Care | 3 | 2001 | 2770 | 0.050 |
Why?
|
Family Practice | 1 | 2006 | 507 | 0.050 |
Why?
|
Polysomnography | 2 | 2008 | 1848 | 0.050 |
Why?
|
Reaction Time | 1 | 2009 | 2087 | 0.050 |
Why?
|
Trazodone | 2 | 1993 | 67 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2374 | 0.050 |
Why?
|
Melatonin | 1 | 2008 | 668 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22174 | 0.050 |
Why?
|
Dyskinesia, Drug-Induced | 2 | 1984 | 165 | 0.050 |
Why?
|
Research | 5 | 2003 | 1976 | 0.050 |
Why?
|
Behavior Therapy | 1 | 2008 | 875 | 0.050 |
Why?
|
Seizures | 1 | 1995 | 2965 | 0.050 |
Why?
|
United States | 14 | 2011 | 72339 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2008 | 12976 | 0.050 |
Why?
|
Interview, Psychological | 3 | 1995 | 809 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 4 | 1988 | 1241 | 0.050 |
Why?
|
Personality Disorders | 1 | 2006 | 719 | 0.050 |
Why?
|
Fear | 1 | 2010 | 1477 | 0.050 |
Why?
|
Half-Life | 3 | 1991 | 649 | 0.040 |
Why?
|
Mood Disorders | 2 | 2003 | 1124 | 0.040 |
Why?
|
Cues | 1 | 2005 | 874 | 0.040 |
Why?
|
Therapeutic Equivalency | 1 | 2000 | 134 | 0.040 |
Why?
|
Dibenzothiazepines | 1 | 2000 | 102 | 0.040 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1381 | 0.040 |
Why?
|
Quality of Life | 2 | 2015 | 13367 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2007 | 64681 | 0.040 |
Why?
|
Dreams | 1 | 2001 | 146 | 0.040 |
Why?
|
Personality Inventory | 7 | 1993 | 1018 | 0.040 |
Why?
|
Accidental Falls | 1 | 2008 | 1068 | 0.040 |
Why?
|
Treatment Failure | 1 | 2006 | 2643 | 0.040 |
Why?
|
Biological Availability | 1 | 2000 | 389 | 0.040 |
Why?
|
Violence | 1 | 1986 | 935 | 0.040 |
Why?
|
Research Design | 2 | 2008 | 6180 | 0.040 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1880 | 0.040 |
Why?
|
New Jersey | 3 | 2004 | 295 | 0.040 |
Why?
|
Risk Assessment | 4 | 2013 | 24021 | 0.040 |
Why?
|
Scientific Misconduct | 1 | 1999 | 74 | 0.040 |
Why?
|
Neural Pathways | 1 | 2009 | 3056 | 0.040 |
Why?
|
Pilot Projects | 2 | 2007 | 8642 | 0.040 |
Why?
|
Risk | 3 | 1999 | 9616 | 0.040 |
Why?
|
Cyclohexanols | 1 | 1999 | 126 | 0.040 |
Why?
|
Financing, Government | 1 | 1982 | 472 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 1989 | 2756 | 0.040 |
Why?
|
Dopamine | 1 | 2005 | 1601 | 0.040 |
Why?
|
Hospitals, State | 2 | 1990 | 28 | 0.040 |
Why?
|
New York | 3 | 2006 | 875 | 0.040 |
Why?
|
Drug Evaluation | 4 | 1991 | 641 | 0.040 |
Why?
|
Frontal Lobe | 1 | 2024 | 1416 | 0.040 |
Why?
|
Neurosurgery | 1 | 2024 | 679 | 0.040 |
Why?
|
Community Mental Health Services | 3 | 1990 | 387 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2691 | 0.040 |
Why?
|
Chronic Disease | 5 | 2001 | 9319 | 0.040 |
Why?
|
Placebos | 9 | 1998 | 1666 | 0.040 |
Why?
|
Risk Factors | 5 | 2013 | 74239 | 0.040 |
Why?
|
Receptors, GABA | 1 | 1999 | 312 | 0.040 |
Why?
|
Self Concept | 4 | 1976 | 1046 | 0.040 |
Why?
|
Serotonin | 1 | 2001 | 1042 | 0.030 |
Why?
|
Patient Rights | 1 | 1977 | 126 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2024 | 1695 | 0.030 |
Why?
|
Paranoid Disorders | 2 | 1987 | 61 | 0.030 |
Why?
|
Decision Making | 1 | 2010 | 3931 | 0.030 |
Why?
|
Aged, 80 and over | 9 | 2007 | 58952 | 0.030 |
Why?
|
Depression, Chemical | 1 | 1995 | 184 | 0.030 |
Why?
|
Nursing Assessment | 1 | 1995 | 106 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1401 | 0.030 |
Why?
|
Tablets | 2 | 2007 | 148 | 0.030 |
Why?
|
Personality | 3 | 1975 | 553 | 0.030 |
Why?
|
Echothiophate Iodide | 1 | 1974 | 1 | 0.030 |
Why?
|
Thyroxine | 1 | 1998 | 665 | 0.030 |
Why?
|
Research Personnel | 1 | 1999 | 588 | 0.030 |
Why?
|
Carbamazepine | 1 | 1995 | 224 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2002 | 1409 | 0.030 |
Why?
|
Professional Practice | 1 | 1976 | 313 | 0.030 |
Why?
|
Attitude to Health | 2 | 1995 | 2026 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 1780 | 0.030 |
Why?
|
Frustration | 4 | 1977 | 22 | 0.030 |
Why?
|
Secobarbital | 1 | 1973 | 2 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1663 | 0.030 |
Why?
|
Narcolepsy | 1 | 1976 | 199 | 0.030 |
Why?
|
Terminology as Topic | 2 | 2010 | 1528 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1993 | 208 | 0.030 |
Why?
|
Apnea | 1 | 1974 | 195 | 0.030 |
Why?
|
Cholinesterase Inhibitors | 1 | 1974 | 241 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1977 | 785 | 0.020 |
Why?
|
Longitudinal Studies | 4 | 2003 | 14610 | 0.020 |
Why?
|
Clinical Competence | 1 | 2008 | 4788 | 0.020 |
Why?
|
Electrocardiography | 1 | 1985 | 6387 | 0.020 |
Why?
|
Hydrocortisone | 2 | 1993 | 1818 | 0.020 |
Why?
|
Rats | 1 | 2008 | 23704 | 0.020 |
Why?
|
Behavior | 2 | 1972 | 540 | 0.020 |
Why?
|
Catecholamines | 1 | 1993 | 387 | 0.020 |
Why?
|
Breast Feeding | 1 | 2020 | 1356 | 0.020 |
Why?
|
Kinetics | 3 | 1985 | 6312 | 0.020 |
Why?
|
Metabolic Clearance Rate | 2 | 1982 | 362 | 0.020 |
Why?
|
Prolactin | 1 | 1993 | 625 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2007 | 3691 | 0.020 |
Why?
|
Biotransformation | 2 | 1982 | 166 | 0.020 |
Why?
|
Maine | 1 | 2011 | 146 | 0.020 |
Why?
|
Psychoses, Substance-Induced | 1 | 1991 | 99 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36415 | 0.020 |
Why?
|
Night Care | 1 | 1969 | 28 | 0.020 |
Why?
|
Adolescent | 8 | 2011 | 88298 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2005 | 5775 | 0.020 |
Why?
|
Receptors, GABA-A | 1 | 1993 | 621 | 0.020 |
Why?
|
Hallucinogens | 1 | 1972 | 197 | 0.020 |
Why?
|
Training Support | 2 | 1982 | 108 | 0.020 |
Why?
|
Memory Disorders | 3 | 1982 | 1198 | 0.020 |
Why?
|
Sleep Stages | 2 | 2001 | 695 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2008 | 26071 | 0.020 |
Why?
|
Sleep, REM | 2 | 2001 | 595 | 0.020 |
Why?
|
Cost Control | 1 | 1990 | 627 | 0.020 |
Why?
|
Methylphenidate | 1 | 1992 | 488 | 0.020 |
Why?
|
Child | 6 | 2010 | 80152 | 0.020 |
Why?
|
Collagen Diseases | 1 | 1967 | 39 | 0.020 |
Why?
|
Geriatric Psychiatry | 1 | 2008 | 70 | 0.020 |
Why?
|
Administration, Oral | 2 | 2007 | 4015 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1969 | 392 | 0.020 |
Why?
|
Drug Approval | 1 | 1994 | 812 | 0.020 |
Why?
|
Drug Costs | 1 | 1995 | 1183 | 0.020 |
Why?
|
Program Evaluation | 2 | 2006 | 2489 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1597 | 0.020 |
Why?
|
Acute Disease | 2 | 1991 | 7226 | 0.020 |
Why?
|
Verbal Behavior | 2 | 1977 | 335 | 0.020 |
Why?
|
Health Services | 1 | 2011 | 750 | 0.020 |
Why?
|
Malpractice | 1 | 1990 | 553 | 0.020 |
Why?
|
Sleep | 1 | 2001 | 4759 | 0.020 |
Why?
|
Causality | 1 | 1991 | 1244 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2003 | 5333 | 0.020 |
Why?
|
Child Psychiatry | 1 | 2008 | 227 | 0.020 |
Why?
|
Nadolol | 1 | 1984 | 29 | 0.020 |
Why?
|
Hospitals, General | 2 | 1980 | 799 | 0.010 |
Why?
|
MMPI | 3 | 1975 | 81 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1990 | 1664 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 14025 | 0.010 |
Why?
|
Child Abuse | 1 | 1993 | 1076 | 0.010 |
Why?
|
Hospitals, Proprietary | 1 | 1984 | 39 | 0.010 |
Why?
|
Glaucoma | 1 | 1974 | 1186 | 0.010 |
Why?
|
Propanolamines | 1 | 1984 | 163 | 0.010 |
Why?
|
Drug Combinations | 1 | 1990 | 2048 | 0.010 |
Why?
|
Confusion | 1 | 1986 | 278 | 0.010 |
Why?
|
Reference Standards | 1 | 2007 | 1005 | 0.010 |
Why?
|
Communication | 2 | 1995 | 3872 | 0.010 |
Why?
|
Patient Selection | 1 | 1995 | 4246 | 0.010 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1992 | 1492 | 0.010 |
Why?
|
California | 1 | 2007 | 1431 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 8457 | 0.010 |
Why?
|
Propranolol | 1 | 1984 | 490 | 0.010 |
Why?
|
Hospitals, Public | 1 | 1984 | 201 | 0.010 |
Why?
|
Utilization Review | 1 | 1984 | 382 | 0.010 |
Why?
|
Social Behavior | 3 | 1974 | 1136 | 0.010 |
Why?
|
Fatigue | 2 | 1983 | 1550 | 0.010 |
Why?
|
Psychological Tests | 3 | 1975 | 639 | 0.010 |
Why?
|
Family | 1 | 1973 | 3192 | 0.010 |
Why?
|
Prevalence | 2 | 1996 | 15721 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 1984 | 395 | 0.010 |
Why?
|
Time | 1 | 2003 | 545 | 0.010 |
Why?
|
Intelligence Tests | 2 | 1973 | 503 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1402 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1995 | 3200 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1995 | 3253 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 1996 | 15841 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1984 | 1123 | 0.010 |
Why?
|
Medicare | 1 | 1999 | 6773 | 0.010 |
Why?
|
Psychometrics | 1 | 2010 | 3061 | 0.010 |
Why?
|
Barbiturates | 1 | 1981 | 113 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6486 | 0.010 |
Why?
|
Thematic Apperception Test | 2 | 1977 | 40 | 0.010 |
Why?
|
Aging | 4 | 2003 | 8702 | 0.010 |
Why?
|
Amnesia | 1 | 1982 | 255 | 0.010 |
Why?
|
Periodicity | 1 | 2001 | 347 | 0.010 |
Why?
|
Cause of Death | 1 | 2010 | 3688 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2003 | 420 | 0.010 |
Why?
|
Cerebrovascular Circulation | 2 | 1984 | 2725 | 0.010 |
Why?
|
Flurazepam | 1 | 1979 | 8 | 0.010 |
Why?
|
Faculty, Medical | 1 | 2008 | 1205 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2001 | 39126 | 0.010 |
Why?
|
Ferricyanides | 1 | 1978 | 31 | 0.010 |
Why?
|
Eyelids | 1 | 2001 | 278 | 0.010 |
Why?
|
Digitalis Glycosides | 1 | 1978 | 47 | 0.010 |
Why?
|
Anemia, Pernicious | 1 | 1978 | 15 | 0.010 |
Why?
|
Societies, Medical | 1 | 1991 | 3923 | 0.010 |
Why?
|
Nitroprusside | 1 | 1978 | 272 | 0.010 |
Why?
|
Parathyroid Diseases | 1 | 1978 | 46 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1978 | 111 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36169 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2001 | 355 | 0.010 |
Why?
|
Cortisone | 1 | 1978 | 87 | 0.010 |
Why?
|
Dexamethasone | 1 | 1985 | 1945 | 0.010 |
Why?
|
Hypochondriasis | 1 | 1978 | 93 | 0.010 |
Why?
|
Defense Mechanisms | 1 | 1978 | 180 | 0.010 |
Why?
|
Paternalism | 1 | 1977 | 48 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59221 | 0.010 |
Why?
|
Antiparkinson Agents | 1 | 1978 | 184 | 0.010 |
Why?
|
Jurisprudence | 1 | 1977 | 109 | 0.010 |
Why?
|
Antiemetics | 1 | 1979 | 186 | 0.010 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1998 | 190 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1989 | 3571 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2393 | 0.010 |
Why?
|
Schizotypal Personality Disorder | 1 | 1978 | 289 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20119 | 0.010 |
Why?
|
Civil Rights | 1 | 1977 | 131 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1998 | 411 | 0.010 |
Why?
|
Child, Preschool | 1 | 1999 | 42224 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12474 | 0.010 |
Why?
|
Marital Therapy | 1 | 1976 | 44 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 1985 | 1176 | 0.010 |
Why?
|
Forensic Psychiatry | 1 | 1977 | 196 | 0.010 |
Why?
|
Methaqualone | 1 | 1975 | 4 | 0.010 |
Why?
|
Career Choice | 1 | 1982 | 757 | 0.010 |
Why?
|
Urologic Diseases | 1 | 1978 | 247 | 0.010 |
Why?
|
Motor Skills | 2 | 1975 | 521 | 0.010 |
Why?
|
Head | 1 | 2001 | 922 | 0.010 |
Why?
|
Delirium | 1 | 1987 | 1668 | 0.010 |
Why?
|
Sex Factors | 2 | 1984 | 10553 | 0.010 |
Why?
|
Patient Advocacy | 1 | 1977 | 358 | 0.010 |
Why?
|
Personal Autonomy | 1 | 1977 | 306 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1978 | 386 | 0.010 |
Why?
|
Butyrylcholinesterase | 1 | 1974 | 21 | 0.010 |
Why?
|
Students, Medical | 1 | 2008 | 1940 | 0.010 |
Why?
|
Movement | 1 | 2001 | 1476 | 0.010 |
Why?
|
Phenothiazines | 1 | 1974 | 61 | 0.010 |
Why?
|
Marriage | 1 | 1976 | 349 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1984 | 3770 | 0.010 |
Why?
|
Tape Recording | 1 | 1973 | 77 | 0.010 |
Why?
|
Mescaline | 1 | 1972 | 7 | 0.010 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1993 | 93 | 0.010 |
Why?
|
Equipment Design | 1 | 2001 | 3510 | 0.010 |
Why?
|
Prospective Studies | 2 | 2003 | 54435 | 0.010 |
Why?
|
Lysergic Acid Diethylamide | 1 | 1972 | 47 | 0.010 |
Why?
|
Videotape Recording | 1 | 1974 | 336 | 0.010 |
Why?
|
Social Isolation | 1 | 1976 | 365 | 0.010 |
Why?
|
Hyperbaric Oxygenation | 1 | 1974 | 165 | 0.010 |
Why?
|
Hypertension | 2 | 1985 | 8536 | 0.010 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 1976 | 360 | 0.010 |
Why?
|
Heart | 1 | 1985 | 4431 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15308 | 0.010 |
Why?
|
Informed Consent | 1 | 1977 | 1008 | 0.010 |
Why?
|
Interpersonal Relations | 2 | 1977 | 1437 | 0.010 |
Why?
|
Social Perception | 1 | 1974 | 431 | 0.010 |
Why?
|
Cohort Studies | 2 | 2004 | 41496 | 0.010 |
Why?
|
Serum Albumin | 1 | 1974 | 674 | 0.010 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1974 | 411 | 0.010 |
Why?
|
Problem Solving | 1 | 1973 | 443 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1998 | 1201 | 0.010 |
Why?
|
Benzopyrans | 1 | 1970 | 63 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2001 | 2569 | 0.010 |
Why?
|
Voice | 1 | 1973 | 268 | 0.010 |
Why?
|
Social Behavior Disorders | 1 | 1969 | 96 | 0.010 |
Why?
|
Gambling | 1 | 1972 | 258 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1978 | 2019 | 0.000 |
Why?
|
Logistic Models | 1 | 2003 | 13249 | 0.000 |
Why?
|
Electroencephalography | 1 | 1984 | 6242 | 0.000 |
Why?
|
Parent-Child Relations | 1 | 1973 | 762 | 0.000 |
Why?
|
Speech | 1 | 1973 | 554 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 7046 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1978 | 2632 | 0.000 |
Why?
|
Boston | 1 | 1980 | 9327 | 0.000 |
Why?
|
Primary Health Care | 1 | 2003 | 4678 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1981 | 4487 | 0.000 |
Why?
|
Educational Status | 1 | 1973 | 2510 | 0.000 |
Why?
|
Students | 1 | 1975 | 1737 | 0.000 |
Why?
|
Heart Diseases | 1 | 1978 | 2795 | 0.000 |
Why?
|
Retrospective Studies | 2 | 2004 | 80674 | 0.000 |
Why?
|
Parkinson Disease | 1 | 1978 | 2867 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1984 | 20588 | 0.000 |
Why?
|
Blood Pressure | 2 | 1974 | 8479 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1978 | 5366 | 0.000 |
Why?
|
Life Style | 1 | 1972 | 3907 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1985 | 15520 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1970 | 7804 | 0.000 |
Why?
|
Social Adjustment | 1 | 1978 | 632 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1978 | 933 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1978 | 13632 | 0.000 |
Why?
|
Vertigo | 1 | 1975 | 202 | 0.000 |
Why?
|
Ataxia | 1 | 1975 | 305 | 0.000 |
Why?
|
Disorders of Excessive Somnolence | 1 | 1975 | 277 | 0.000 |
Why?
|
Euphoria | 1 | 1970 | 65 | 0.000 |
Why?
|
Pulse | 1 | 1970 | 218 | 0.000 |
Why?
|
Choice Behavior | 1 | 1975 | 825 | 0.000 |
Why?
|
Psychology | 1 | 1970 | 356 | 0.000 |
Why?
|
Music | 1 | 1970 | 245 | 0.000 |
Why?
|
Body Temperature | 1 | 1970 | 780 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1975 | 2189 | 0.000 |
Why?
|
Length of Stay | 1 | 1978 | 6417 | 0.000 |
Why?
|
Perception | 1 | 1970 | 1198 | 0.000 |
Why?
|